First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.

Item

http://www.wikidata.org/entity/Q24812405

description

2005 nî lūn-bûn

@nan

2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

First-line therapy with gemcit ...... reast cancer: a phase II study

@nl

First-line therapy with gemcit ...... east cancer: a phase II study.

@ast

First-line therapy with gemcit ...... east cancer: a phase II study.

@en

type

Item

label

First-line therapy with gemcit ...... reast cancer: a phase II study

@nl

First-line therapy with gemcit ...... east cancer: a phase II study.

@ast

First-line therapy with gemcit ...... east cancer: a phase II study.

@en

prefLabel

First-line therapy with gemcit ...... reast cancer: a phase II study

@nl

First-line therapy with gemcit ...... east cancer: a phase II study.

@ast

First-line therapy with gemcit ...... east cancer: a phase II study.

@en

P1476

First-line therapy with gemcit ...... east cancer: a phase II study.

@en

P2093

Djelila Allouache

http://www.w3.org/2001/XMLSchema#string

Fawzia Mefti

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Genot

http://www.w3.org/2001/XMLSchema#string

Laurence Bozec

http://www.w3.org/2001/XMLSchema#string

Michele Tubiana-Hulin

http://www.w3.org/2001/XMLSchema#string

Nicole Tubiana-Mathieu

http://www.w3.org/2001/XMLSchema#string

Sulochana R Gawande

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2002

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane.

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.

Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer.

Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer.

Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer.

Single-agent gemcitabine is active in previously treated metastatic breast cancer.

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial.

Gemcitabine plus paclitaxel as first-line chemotherapy for patients with advanced breast cancer.

P2888

1471-2407-5-151

P304

151

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4702096

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2407-5-151

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sophie Piperno-Neumann

Nicole Tubiana Mathieu

P577

2005-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7453485

http://www.w3.org/2001/XMLSchema#string

P6179

1046965588

http://www.w3.org/2001/XMLSchema#string

P698

16316459

http://www.w3.org/2001/XMLSchema#string

P932

1315334

http://www.w3.org/2001/XMLSchema#string